India Jai and Sameer Hiremath of Hikal provide insights into the main trends shaping the Indian and global CDMO industry. They articulate how Hikal’s long-standing focus on quality standards, regulatory compliance, and good governance has enabled the company to avoid regulatory issues and gain the trust of the world’s most respected…
Canada Dwight Gorham, president and CEO of Pillar5 Pharma, discusses the unique positioning of the CDMO in the multi-dose preservative free sterile ophthalmics space and stresses the importance of anticipating market trends in order to fuel expansion. Finally, he gives an insight into the importance of honing new skills and how…
Pharma India leads the way in terms of the sheer volume of US FDA-approved manufacturing plants with over 100, compared to only 28 in China. In terms of the global competitiveness of Brazil, Russia, India, China and South Africa (BRICS), China remained out in front between 2012 and 2015, with India…
Canada Halo Pharma, a US-based one-stop-shop CDMO (Contract Development and Manufacturing Organization), operates out of a site in Mirabel, close to Montreal, that boasts 30 years of experience in developing and manufacturing medicine. Maryse Laliberté, Halo Pharma’s vice-president and general manager, highlights the company’s differentiation factors of quality delivery and flexibility,…
Canada Oliver Technow, president at BioVectra, highlights the company’s recent developments; amongst those a significant investment in a manufacturing site near Halifax. The resulting increase in manufacturing capacity by 40 percent will add to BioVectra’s position as the largest biotechnology company on Prince Edward Island, a historic location the CDMO is…
Switzerland Karen Huebscher, CEO of Solvias, a Swiss-headquartered world leader in contract research, development and manufacturing, explains her decision to join the company after a distinguished career at Novartis, the evolution of pharmaceutical client demands, and Solvias’s evolving international footprint. After more than 15 years with Switzerland’s largest life sciences group…
Switzerland Marc Funk, COO of Swiss-headquartered product development service specialist, Lonza, discusses the company’s remarkable recent fortunes, how it is implementing innovative efficiency improvements, and answers the question, “why Switzerland?” We aspire to move the company and the relationship with our customers from being a functional service provider to the strategic partner…
Switzerland The managing director of CordenPharma Switzerland elaborates on the role the Swiss facility plays within CordenPharma. He furthermore highlights how the company is tailoring their service offering to cater to the needs of multi-national companies, mid-sized companies as well as start-ups. You worked in various positions in Lonza for 27…
Switzerland www.celonic.com CEO of Swiss biologics CDMO Celonic, Konstantin Matentzoglu, explains how the company attracts talented and experienced staff and what makes it the partner of choice in Switzerland and beyond. Celonic is in many ways more than a CDMO for biologics. What is the strategic focus of this company? “Our…
Ireland Dr. Paul Downing, General Manager of Hovione’s manufacturing plant in Cork, outlines the successes of the past few years, his emphasis on staff development and training, the CDMO’s advantages of agility and responsiveness, Ireland’s value proposition for the pharma manufacturing industry, and his vision for the next few years. Can…
Pharma Doppel has been selected as the nucleus for significant investments in the CDMO industry by PE firm Trilantic Capital Partners, according to recently hired CEO Giuseppe Cassisi, who shares the organization’s plans to invest in both greenfield facilities and M&A in the coming years. Italy’s pharmaceutical exports are growing faster than any other…
Pharma Giorgio Bruno, CEO of Recipharm Italy, gives an insight into the success factors of the CDMO, discusses the recent acquisition of Mitim, and explains how this acquisition helps Recipharm not only achieve their growth ambitions but also provide better services to its clients. You were appointed CEO of Recipharm Italy…
See our Cookie Privacy Policy Here